Your browser doesn't support javascript.
loading
Phase I/II study of intermitted erlotinib in combination with docetaxel in patients with recurrent non-small cell lung cancer (WJOG4708L).
Kimura, Tatsuo; Kawaguchi, Tomoya; Chiba, Yasutaka; Yoshioka, Hiroshige; Watanabe, Katsuya; Kijima, Takashi; Kogure, Yoshihito; Oguri, Tetsuya; Yoshimura, Naruo; Niwa, Takashi; Kasai, Takashi; Hayashi, Hidetoshi; Ono, Akira; Asai, Kazuhisa; Tanaka, Hiroshi; Yano, Seiji; Yamamoto, Nobuyuki; Nakanishi, Yoichi; Nakagawa, Kazuhiko.
Afiliação
  • Kimura T; Graduate School of Medicine, Osaka City University 1-4-3, Asahimachi, Abeno-ku, Osaka-City Osaka, Japan.
  • Kawaguchi T; Graduate School of Medicine, Osaka City University 1-4-3, Asahimachi, Abeno-ku, Osaka-City Osaka, Japan.
  • Chiba Y; Kinki University Faculty of Medicine 377-2, Ohno-Higashi, Osaka-Sayama-City, Osaka, Japan.
  • Yoshioka H; Kurashiki Central Hospital 1-1-1 Miwa, Kurasiki-City Okayama, Japan.
  • Watanabe K; Yokohama Medical Center 3-60-2 Harajuku, Totsuka-ku, Yokohama-City, Kanagawa, Japan.
  • Kijima T; Graduate School of Medicine, Osaka University 2-15, Yamadaoka, Suita-City, Osaka, Japan.
  • Kogure Y; Nagoya Medical Center 4-1-1 Sannomaru, Naka-ku, Nagoya-City, Aichi, Japan.
  • Oguri T; Nagoya City University 1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya-City, Aichi, Japan.
  • Yoshimura N; Graduate School of Medicine, Osaka City University 1-4-3, Asahimachi, Abeno-ku, Osaka-City Osaka, Japan.
  • Niwa T; Kurashiki Central Hospital 1-1-1 Miwa, Kurasiki-City Okayama, Japan.
  • Kasai T; Tochigi Cancer Center 4-9-13 Yonan, Utsunomiya-City, Tochigi, Japan.
  • Hayashi H; Kinki University Faculty of Medicine 377-2, Ohno-Higashi, Osaka-Sayama-City, Osaka, Japan.
  • Ono A; Shizuoka Cancer Center 1007 Shimonagakubo, Nagaizumi-cho, Sunto-Gun, Shizuoka, Japan.
  • Asai K; Graduate School of Medicine, Osaka City University 1-4-3, Asahimachi, Abeno-ku, Osaka-City Osaka, Japan.
  • Tanaka H; Niigata Cancer Center Hospital 2-15-3 Kawagishi-Cho, Chuo-Ku, Niigata-City, Niigata, Japan.
  • Yano S; Kanazawa University 13-1 Takara-machi, Kanazawa-City, Ishikawa, Japan.
  • Yamamoto N; Wakayama Medical University 811-1 Kimiidera Wakayama-City, Wakayama, Japan.
  • Nakanishi Y; Kyushu University 3-1-1 Maidashi, Higashi-ku, Fukuoka-City, Fukuoka, Japan.
  • Nakagawa K; Kinki University Faculty of Medicine 377-2, Ohno-Higashi, Osaka-Sayama-City, Osaka, Japan.
Jpn J Clin Oncol ; 49(10): 947-955, 2019 Oct 01.
Article em En | MEDLINE | ID: mdl-31242302
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Cloridrato de Erlotinib / Docetaxel / Neoplasias Pulmonares / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Jpn J Clin Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Cloridrato de Erlotinib / Docetaxel / Neoplasias Pulmonares / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Jpn J Clin Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão